MedPath

ICMR Fungal Infection Registry

Not Applicable
Conditions
Health Condition 1: B49- Unspecified mycosis
Registration Number
CTRI/2022/09/045489
Lead Sponsor
Indian Council of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ICU/Hospitalized patients of any age and gender with invasive fungal infections confirmed by culture, histopathology, microscopy or DNA evidence, as per the EORTC/MSG criteria, 2019 and Blot criteria 2012,19 (only proven and probable IFI cases)

2.All hospitalised cases of Mycetoma and chromoblastomycosis

Exclusion Criteria

1.OPD patients

2.Possible cases and patients without evidence of invasive disease or those with colonisation only are not eligible.

3.Patients with superficial infections, and allergic fungal diseases like allergic bronchopulmonary aspergillosis will not be included.

4.Infection limited to the skin only will also be excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital-based prevalence of invasive fungal infectionsTimepoint: Period which may be needed for initiating the Registry database and CRF: three months. <br/ ><br>Period which may be needed for collecting the data: Continuously from three months onwards <br/ ><br>Period that may be required for analyzing the data: Continuously from six months onwards.
Secondary Outcome Measures
NameTimeMethod
Identifying risk factors of invasive fungal infections among ICU patientsTimepoint: Period which may be needed for initiating the Registry database and CRF: three months. <br/ ><br>Period which may be needed for collecting the data: Continuously from three months onwards <br/ ><br>Period that may be required for analyzing the data: Continuously from six months onwards.
© Copyright 2025. All Rights Reserved by MedPath